Company

Prothena Corporation plc

Headquarters: Dublin, Ireland

Employees: 82

CEO: Dr. Gene G. Kinney Ph.D.

NASDAQ: PRTA -1.55%

Market Cap

$2.17 Billion

USD as of Jan. 1, 2024

Market Cap History

Prothena Corporation plc market capitalization over time

Evolution of Prothena Corporation plc market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Prothena Corporation plc

Detailed Description

Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a humanized monoclonal antibody, which is in Phase IIb clinical trial for the treatment of Parkinson's disease; PRX004 that completed Phase I clinical trial for the treatment of Transthyretin amyloidosis; and PRX005, which is in Phase I clinical trial for the treatment of Alzheimer's disease. Its discovery and preclinical programs include PRX012 for the treatment of Alzheimer's disease; and dual AàŸ-Tau vaccine for the treatment and prevention of Alzheimer's disease. Prothena Corporation plc has a license, development, and commercialization agreement with F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. to develop and commercialize antibodies that target alpha-synuclein; and a collaboration agreement with Bristol-Myers Squibb to develop antibodies. The company was founded in 2012 and is based in Dublin, Ireland.

Top 1-year algo backtest: +287.69%

$10,000 in March 2023 would now be $38,769 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Stocks & Indices

Prothena Corporation plc has the following listings and related stock indices.


Stock: NASDAQ: PRTA wb_incandescent

Stock: FSX: 0PT wb_incandescent

Details

Headquarters:

77 Sir John Rogerson’s Quay

Block C Grand Canal Docklands

Dublin, 2

Ireland

Phone: 353 1 236 2500

Fax: 353 1 902 3510